End of Month - January 2020End of the Month Report for January 2020 for Illumina Inc.
-
ILMN closed on 01/31/2020 at US$ 290.07
ILMN closed on 12/31/2019 at US$ 331.74
-
This is a 12.6% loss, a US$ 41.67 loss, for Janury
-
S&P 500 Index, @ 3225.5 lost 0.5% in January. [7.1% above its MA(200) @ 3011.8]
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's MA(200) ended January at US$313.24
ILMN is now 7.4% below its MA(200).
-
News Releases on the ILMN Website in January -
Jan 29, 2020
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -
https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=005f3f8e-567b-478a-8e15-609e45bef4d2 -
Jan 13, 2020
Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
-
Jan 13, 2020
Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
-
Jan 13, 2020
Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
-
Jan 10, 2020
Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
-
Jan 2, 2020
Illumina and Pacific Biosciences Announce Termination of Merger Agreement
-
Who is in charge? Francis A. DeSouza, CEO
-
RJ